Congratulations to the team at VectorY for being awarded the 2021 European Advance Biotech Grant grand prize of €255,000 in products, services and consultation. With a large number of applicants this year, 6 semi-finalist companies were selected to present directly to the panel of judges, from there- 3 finalist companies were selected to move forward. Two companies, Asgard Therapeutics and ImmTune Therapies, will receive $10,000 in products and services. The Advance Biotech Grant Program is a global program that helps biotech startups understand the challenges in the quest to push the next generation of drugs to market.
- Biotech Hubs, Incubators and Clusters: Why You Need More Than Just Lab Space - January 28, 2022
- The Post-COVID-19 State of Biomanufacturing News from the Biotech Start-up Symposium - January 18, 2022
- Another Successful Biotech Start-Up Symposium Is In The Books - January 7, 2022